Vancouver, Washington — September 4, 2025 — Leads & Copy — CytoDyn Inc. (OTCQB: CYDY) announced a time change for management’s live presentation at the H.C. Wainwright 27th Annual Global Investment Conference. The presentation is now scheduled for Wednesday, September 10, at 9 a.m. EDT.
CytoDyn CFO, Robert E. Hoffman, will present live and be available for one-on-one meetings during the event, which takes place September 8-10, 2025, in New York City. The webcast registration details are available here.
CytoDyn is focused on advancing leronlimab, a humanized monoclonal antibody targeting the CCR5 receptor for cancer, infectious diseases, and autoimmune disorders.
Investor Relations can be contacted at ir@cytodyn.com. Media contacts are Rob Haney, Ph.D., or Ignacio Guerrero-Ros, Ph.D. at CytoDyn@russopartnersllc.com.
Source: CytoDyn Inc.
